Global Intracranial Aneurysm Market Grows Steadily at a CAGR of 10.1%

Introduction

Brain or cerebral aneurysms are intracranial aneurysms. Aneurysms are weakened and bulging brain artery regions and are expected in the brain's frontal artery. The affected region swells, widens, and blebs in an intracranial aneurysm. Aneurysms weaken artery walls, increasing the risk of rupture. These arteries carry oxygen-rich blood to the body's blood tissues, which use it. Intracranial aneurysms can be examined in three layers. When there is no muscle layer in the artery walls, or when it is misled, the entire burden of supporting the artery falls on the other two layers, making them fragile and thin.

Market Dynamics

Dramatic Increase in Diseases and Expanding Intracranial Aneurysm Research Drives the Global Market

High blood pressure and blood vessel trauma also drive the intracranial aneurysms market. Hypertension increases the risk of brain aneurysms and other diseases. Due to high blood pressure and smoking, many people are at risk for brain aneurysms. Unruptured brain aneurysms are increasing in elderly patients, especially those 70 and older.

The market for intracranial aneurysms is expected to grow significantly over the next few years due to increased research and development programs focused on treating intracranial aneurysms. Several international institutes actively research brain aneurysm diagnosis, many of which collaborate. Brain aneurysms will be identified and evaluated using artificial intelligence, widely implemented in nationwide medical settings.

Rising Government Programs Creates Tremendous Opportunities

Preference for minimally invasive procedures and available medicines and devices contributes to market growth. Expanding government spending on healthcare, incorporating cutting-edge technology into medical equipment, and increasing research and development efforts are expected to boost the market.

Regional Analysis

North America is dominating the global intracranial aneurysm market during the forecast period. The population's aging trend, growing public awareness of the value of maintaining one's health, and rising consumer demand for cutting-edge healthcare and medical technology are all contributing factors to this growth.

Key Highlights

• The global intracranial aneurysm market was valued at USD 1.92 billion in 2021. It is expected to reach USD 3.92 billion by 2030, growing at a CAGR of 10.1% during the forecast period (2022–2030).
• Based on type, the intracranial aneurysm market is segmented into Endovascular Coiling, Surgical Clipping, and Flow Diverters. It is anticipated that Endovascular Coiling will take the lead in the market during the forecast period.
• Based on end-user, the global intracranial aneurysm market is bifurcated into Hospitals and Ambulatory Surgical Centers. Hospital segments will record significant growth shortly due to the increasing number of patients worldwide.
• North America is dominating the global intracranial aneurysm market during the forecast period.

Competitive Players

1. Adept Medical
2. B. Braun
3. Codman Neuro (Integra LifeSciences)
4. DePuy Synthes
5. Evasc Medical Systems
6. Infrascan
7. Johnson and Johnson Services
8. Kaneka
9. Medtronic
10. Microport Scientific
11. MicroVention
12. Mizuho Medical
13. Orsan Medical Technologies
14. Penumbra
15. Raumedic
16. Sophia
17. Spiegelberg (SHS Medizintechnik)
18. Stryker
19. Terumo
20. Vittamed

Recent Developments

• June 2022, P. Moller – Maersk to acquire ResQ to strengthen Maersk Training's offerings within safety training and emergency preparedness.
• In June 2022, Maersk to launch a dedicated coastal service in New Zealand.
• In June 2022, P. Moller - Maersk completed the acquisition of Senator International.
• In June 2022, OBE Organic will collaborate with Maersk on sustainable ECO Delivery.
• In December 2022, Surgical Innovation Associates was fully acquired by Integra LifeSciences.
• In October 2022, FDA Approved TELIGENTM System by DePuy Synthes.
• In February 2023, In patients with ischemic stroke, the Medtronic LINQ Insertable Cardiac Monitor detects atrial fibrillation ten times more frequently at three years than the standard of care.

Segmentation

1. By Type 
   1. Surgical Clipping
   2. Endovascular Coiling
   3. Flow Diverters
2. By End-Use 
   1. Hospitals
   2. Clinics